Showing results (1-10 of 17) with videos related to
Sort By:
Pageof 2
Blood|August 26, 2021
EBV+ lymphoproliferative diseases: opportunities for leveraging EBV as a therapeutic targetKeri Toner, Catherine M BollardCytotherapy|July 20, 2019
T-cell therapies for T-cell lymphomaKeri Toner, Catherine M Bollard, Hema DaveSeminars in Hematology|February 9, 2024
CD19 CAR-T cell therapy for relapsed or refractory diffuse large B cell lymphoma: Why does it fail?Hannah Kinoshita, Catherine M Bollard, Keri TonerBest Practice & Research. Clinical Haematology|March 12, 2023
Diagnosis and management of post-transplant lymphoproliferative disease following solid organ transplantation in children, adolescents, and young adultsJeremy Rubinstein, Keri Toner, Thomas Gross, et al.Nature Reviews. Clinical Oncology|August 19, 2024
Applications of cell therapy in the treatment of virus-associated cancersKeri Toner, Chase D McCann, Catherine M BollardPediatrics|October 6, 2018
A 17-Year-Old Girl With Weight Loss and Elevated Inflammatory MarkersKeri Toner, Hemalatha Srinivasalu, Michael Guerrera, et al.Journal of Pediatric Hematology/Oncology|December 31, 2024
Pediatric T-lymphoblastic Leukemia With an Entirely Mature Immunophenotype: A Prompt and Challenging DiagnosisJinjun Cheng, Yannan Wang, Shunyou Gong, et al.Molecular Therapy. Methods & Clinical Development|November 3, 2021
Novel TCR-like CAR-T cells targeting an HLA∗0201-restricted SSX2 epitope display strong activity against acute myeloid leukemiaScott Raskin, Stacey Van Pelt, Keri Toner, et al.Academic Pediatrics|August 28, 2017
Children With Medical Complexity: A Web-Based Multimedia Curriculum Assessing Pediatric Residents Across North AmericaNeha H Shah, Priti Bhansali, Aisha Barber, et al.Pediatric Blood & Cancer|January 4, 2024
Pediatric cutaneous T-cell neoplasm and mimics with gamma-delta expression: Not always aggressiveJinjun Cheng, Keri Toner, Kaiane Habeshian, et al.Pageof 2